These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32882450)

  • 1. Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones.
    Davido B; Noussair L; Saleh-Mghir A; Salomon E; Bouchand F; Matt M; Lawrence C; Bauer T; Herrmann JL; Perronne C; Gaillard JL; Rottman M; Dinh A
    J Glob Antimicrob Resist; 2020 Dec; 23():74-78. PubMed ID: 32882450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native bone and joint infections caused by extended-spectrum β-lactamase-producing Enterobacterales: experience of a reference centre in the Greater Paris area.
    Davido B; Saleh-Mghir A; Rottman M; Jaffal K; Salomon E; Bouchand F; Lawrence C; Bauer T; Herrmann JL; De Truchis P; Noussair L; Cremieux AC
    Int J Antimicrob Agents; 2022 Jan; 59(1):106497. PubMed ID: 34906675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
    Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
    J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
    Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
    Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Characteristics of Extended-Spectrum-β-Lactamase-Producing and Carbapenemase-Producing
    Sapugahawatte DN; Li C; Zhu C; Dharmaratne P; Wong KT; Lo N; Ip M
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
    Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.
    Song W; Park MJ; Jeong S; Shin DH; Kim JS; Kim HS; Kim HS; Lee N; Hong JS; Jeong SH
    Ann Lab Med; 2020 May; 40(3):259-263. PubMed ID: 31858767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
    Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
    New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
    Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D
    BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-Abdominal Infections by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    De la Calle C; Rodríguez O; Morata L; Marco F; Cardozo C; García-Vidal C; Río AD; Feher C; Pellicé M; Puerta-Alcalde P; Mensa J; Soriano A; Martínez JA
    Int J Antimicrob Agents; 2019 Apr; 53(4):520-524. PubMed ID: 30471403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
    Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
    Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
    Teethaisong Y; Nakouti I; Evans K; Eumkeb G; Hobbs G
    J Glob Antimicrob Resist; 2019 Sep; 18():22-25. PubMed ID: 30668995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.